Apellis Pharmaceuticals, Inc. (APLS)

24.93 -0.04 (-0.14%) USD  |  NASDAQ  |  Dec 12, 14:37
More

Apellis Pharmaceuticals EBITDA (Quarterly)

EBITDA (Quarterly) Chart

View EBITDA (Quarterly) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (Quarterly) Range, Past 5 Years

View EBITDA (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (Quarterly) Benchmarks

View EBITDA (Quarterly) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade
Fulcrum Therapeutics, Inc. Upgrade